1 |
MC4R
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D11927
D11927
|
Setmelanotide
| [2] 202 202, 265 |
2 |
MTNR1A
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | D08170
D08170
|
Melatonin
| [12] 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
3 |
MTNR1A
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | D09388
D09388
|
Tasimelteon
| [1] 202 202 |
4 |
MTNR1B
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | D08170
D08170
|
Melatonin
| [12] 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
5 |
MTNR1B
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | D09388
D09388
|
Tasimelteon
| [1] 202 202 |
6 |
VDR
| [5] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation | D00188
D00188
|
Cholecalciferol
| [25] 6 6, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 |